Photocatalytic degradation experiments were done with lignin sulfonate in a circulating reactor. Catalysts (TiO2-P25-SiO2 + Pt, TiO2-P25-SiO2, TiOSO4_30.6 wt%, ZnO + TiO2-P25-SiO2), synthesized via the sol–gel method, were immobilized on porous glass support material. A comparative study was done regarding morphology of coatings, degradation rates, reaction rates, dissolved carbon (DC), formation of peaks, and fluorescence of products formed from the photocatalytic degradation of lignin sulfonate obtained from a local paper plant. Through simultaneous reaction–extraction pathways applying dialysis filtration and highly porous polystyrene divinylbenzene adsorbent resin (HR-P) for solid-phase extraction (SPE), an attempt was been made to isolate smaller molecules produced from photocatalytic degradation. Moreover, relatively high lignin sulfonate (0.5 g/L) concentrations are used in the reactions. UV–Vis spectroscopy revealed a faster reduction in the concentration values for the aliphatic moiety compared to the aromatic moiety. Peaks were observed by both fluorescence spectroscopy and high-performance liquid chromotography (HPLC), suggesting the production of new substances and fluorophores.
Part of the book: Semiconductor Photocatalysis
The industrial-scale manufacturing of viruses or virus-like particles in cell culture is necessary for gene therapy and the treatment of cancer with oncolytic viruses. Complex multistep processes are required in both cases, but the low virus titers in batch cultures and the temperature sensitivity of the virus particles limit the production scale. To meet commercial and regulatory requirements, each process must be scalable and reproducible and must yield high virus titers. These requirements are met by establishing a cell culture process that matches the properties of the virus/host-cell system and by using serum-free cell culture medium. This chapter focuses on two case studies to consider the different aspects of process design, such as the reactor configuration and operational mode: the continuous production of retroviral pseudotype vectors in a retroviral packaging cell line and the production of oncolytic measles virus vectors for cancer therapy.
Part of the book: New Insights into Cell Culture Technology
In the field of cell therapy, allogenic human mesenchymal stromal cells (hMSCs) are often used in clinical trials, creating a demand for cell mass production using efficient dynamic bioreactor systems. As an advanced therapy medicinal product (ATMP), such cells should meet certain special requirements, including product specifications requiring a production process compatible with good manufacturing practice (GMP). The development of processes in which the cells are the product therefore remains a significant challenge. This chapter describes the requirements at different steps in the upstream and downstream phases of such dynamic processes. Potential solutions are presented and future prospects are discussed, including the selection of media and carriers for the strictly adherent growing cells, allowing efficient cell adhesion and detachment. Strategies for dynamic cultivation in bioreactors are described in detail for fixed‐bed and stirred‐tank reactors based on GMP requirements and the integration of process analytical technology (PAT). Following cell harvest, separation and purification, the formulation and storage of the product are also described. Finally, the chapter covers important cell quality characteristics necessary for the approval of ATMPs.
Part of the book: New Insights into Cell Culture Technology
Insect cells can be used for the efficient production of heterologous proteins. The baculovirus expression vector system (BEVS) in Spodoptera frugiperda cells and the stable transformation of Drosophila melanogaster S2 cells are widely used for this purpose. Whereas BEVS is a transient expression system for rapid protein production, stable D. melanogaster cell lines are compatible with more complex processes modes. This chapter describes the setup of both systems, including steps for the generation of expression vectors and comprehensive optimization approaches. The genetic elements available in each system are described, as well as the use of different cloning and transfection methods and advanced process monitoring to achieve robust protein expression in larger-scale bioreactors.
Part of the book: New Insights into Cell Culture Technology
Lignin is a heterogeneous, phenolic and polydisperse biopolymer which resists degradation due to its aromatic and highly branched structure. Lignin is the most abundant renewable source of aromatic molecules on earth. The valorization of lignin could therefore provide a sustainable alternative to petroleum refineries for the production of valuable aromatic compounds. Even so, paper mills and lignocellulose feedstock biorefineries treat lignin largely as a waste product. In paper mills, 98% of technical lignin is incinerated for internal energy recovery while only 2% is used commercially (e.g. for the production of aromatics such as vanillin). The reasons for the underutilization of lignin include its recalcitrance to degradation and the challenge of separating mixtures of numerous degradation products. The successful valorization of lignin in the future thus depends on a broad understanding of biological and technical degradation processes, and the implementation of efficient product purification strategies. This article describes enzymatic, photocatalytic and thermochemical lignin degradation processes and considers purification methods for valuable lignin-derived degradation products. We focus on the potential of membrane-based separation technology, including data from our own recent research.
Part of the book: Lignin